Assam Entrade Limited (ASSAMENT.BO)
INR 524.8
(2.0%)
INR 524.8
(2.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 20.87 Million | 22 Million | 38.29 Million | -1.75 Million | 33.96 Million |
| Net Income | 13.39 Million | 14.88 Million | 22.39 Million | 14.11 Million | 15.34 Million |
| Depreciation & Amortization | 1.14 Million | 1.63 Million | 2.49 Million | 4000.00 | 5000.00 |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 279 Thousand | 12.66 Million | 13.68 Million | -9.59 Million | 5.41 Million |
| Other non-cash items | 15.93 Million | 124 Thousand | 6.63 Million | -2.15 Million | -11.21 Million |
| Investing Cash Flow | -45 Thousand | -53.84 Million | -25 Million | 354 Thousand | -557 Thousand |
| Investments in PPE | -20.87 Million | - | -7.97 Million | - | -300 Thousand |
| Acquisitions | - | - | - | - | 500 Thousand |
| Investment purchases | - | -64 Thousand | - | - | -756 Thousand |
| Sales/Maturities of investments | - | 13.79 Million | 2.73 Million | 353 Thousand | - |
| Other Investing Activities | - | -67.58 Million | -19.76 Million | 1000.00 | -1000.00 |
| Financing Cash Flow | -18.43 Million | 18.13 Million | -110 Thousand | -20.25 Million | -10.24 Million |
| Debt repayment | -18.43 Million | -18.13 Million | -110 Thousand | -20.25 Million | -10.24 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 64 Thousand | -876 Thousand | -175 Thousand | 326 Thousand | - |
| Inventory | -7.64 Million | -3.16 Million | -1.76 Million | -4.44 Million | 24.43 Million |
| Other working capital | 7.86 Million | 16.7 Million | 15.62 Million | -5.48 Million | -19.02 Million |
| Cash at beginning of period | 1.62 Million | 16.29 Million | 3.14 Million | 24.82 Million | 1.66 Million |
| Cash at end of period | 3.99 Million | 1.62 Million | 16.29 Million | 3.14 Million | 24.82 Million |
| Capital Expenditure | -20.87 Million | - | -7.97 Million | - | -300 Thousand |
| Effect of forex changes on cash | - | -966 Thousand | -28 Thousand | -30 Thousand | - |
| Net cash flow / Change in cash | 2.37 Million | -14.67 Million | 13.14 Million | -21.67 Million | 23.16 Million |
| Free Cash Flow | - | 22 Million | 30.31 Million | -1.75 Million | 33.66 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13.39 Million | 4.78 Million | 3.94 Million | -478 Thousand | 14.88 Million | 6.36 Million |
| Depreciation & Amortization | 1.14 Million | 287 Thousand | 287.3 Thousand | 287 Thousand | 1.63 Million | 409 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 279 Thousand | - | - | - | 12.66 Million | - |
| Other non-cash items | 15.93 Million | -4.5 Million | -287.3 Thousand | -287 Thousand | 124 Thousand | -409 Thousand |
| Investing Cash Flow | -45 Thousand | - | - | - | -53.84 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -64 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 13.79 Million | - |
| Other Investing Activities | - | - | - | - | -67.58 Million | - |
| Financing Cash Flow | -18.43 Million | - | - | - | 18.13 Million | - |
| Debt repayment | -18.43 Million | - | - | - | -18.13 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 64 Thousand | - | - | - | -876 Thousand | - |
| Inventory | -7.64 Million | - | - | - | -3.16 Million | - |
| Other working capital | 7.86 Million | - | - | - | 16.7 Million | - |
| Cash at beginning of period | 1.62 Million | 3.68 Million | -263.5 Thousand | 1.62 Million | 16.29 Million | -4.74 Million |
| Cash at end of period | 3.99 Million | 4.25 Million | 3.68 Million | -478 Thousand | 1.62 Million | 1.62 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | -966 Thousand | - |
| Net cash flow / Change in cash | 2.37 Million | 574 Thousand | 3.94 Million | -2.09 Million | -14.67 Million | 6.36 Million |
| Free Cash Flow | 20.87 Million | 574 Thousand | 3.94 Million | -478 Thousand | 22 Million | 6.36 Million |
RANEHOLDIN
2168
S63
BIOCON
TRAW
YAK